http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 04 Mar 2026 17:19:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+26/26112738.html si-local-file:///var/storage/secattach/20260304/26112738.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+26/26112738.html Wed, 04 Mar 2026 17:19:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+26/26112738.html si-local-file:///var/storage/secattach/20260304/26112738.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+26/26112738.html Wed, 04 Mar 2026 17:19:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++D++++++++++XWELL%2C+Inc.++++++++++++++++++++++++++/26095605.html si-local-file:///var/storage/secattach/20260303/26095605.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++XWELL%2C+Inc.++++++++++++++++++++++++++/26095605.html Tue, 03 Mar 2026 06:01:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++D++++++++++XWELL%2C+Inc.++++++++++++++++++++++++++/26095605.html si-local-file:///var/storage/secattach/20260303/26095605.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++XWELL%2C+Inc.++++++++++++++++++++++++++/26095605.html Tue, 03 Mar 2026 06:01:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+WEINSTEIN+ROBERT/26094623.html si-local-file:///var/storage/secattach/20260302/26094623.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+WEINSTEIN+ROBERT/26094623.html Mon, 02 Mar 2026 19:46:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+WEINSTEIN+ROBERT/26094623.html si-local-file:///var/storage/secattach/20260302/26094623.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+WEINSTEIN+ROBERT/26094623.html Mon, 02 Mar 2026 19:46:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Lebowitz+Michael/26094617.html si-local-file:///var/storage/secattach/20260302/26094617.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Lebowitz+Michael/26094617.html Mon, 02 Mar 2026 19:44:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Lebowitz+Michael/26094617.html si-local-file:///var/storage/secattach/20260302/26094617.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Lebowitz+Michael/26094617.html Mon, 02 Mar 2026 19:44:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Bernstein+Bruce/26094611.html si-local-file:///var/storage/secattach/20260302/26094611.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Bernstein+Bruce/26094611.html Mon, 02 Mar 2026 19:43:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Bernstein+Bruce/26094611.html si-local-file:///var/storage/secattach/20260302/26094611.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Bernstein+Bruce/26094611.html Mon, 02 Mar 2026 19:43:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Ernst+Ezra/26094614.html si-local-file:///var/storage/secattach/20260302/26094614.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Ernst+Ezra/26094614.html Mon, 02 Mar 2026 19:43:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Ernst+Ezra/26094614.html si-local-file:///var/storage/secattach/20260302/26094614.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Ernst+Ezra/26094614.html Mon, 02 Mar 2026 19:43:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Wizenberg+Gaelle+Sandra/26094604.html si-local-file:///var/storage/secattach/20260302/26094604.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Wizenberg+Gaelle+Sandra/26094604.html Mon, 02 Mar 2026 19:41:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Wizenberg+Gaelle+Sandra/26094604.html si-local-file:///var/storage/secattach/20260302/26094604.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+27++Filed+by%3A+Wizenberg+Gaelle+Sandra/26094604.html Mon, 02 Mar 2026 19:41:00 -0500 O.08204144 XWEL http://www.streetinsider.com/Press+Releases/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html <p>DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning’s tape highlights companies positioning for scale in 2026 and beyond.</p> <p><strong>Totaligent Targets APAC Biologics and Medical Tourism</strong></p> <p>Totaligent (OTCID: TGNT) announced the execution of a <strong>binding Letter of Intent (LOI)</strong> with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent’s recently announced Aetherium Medical platform.</p> <p>The agreement establishes a JV http://www.streetinsider.com/Press+Releases/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html Wed, 25 Feb 2026 09:38:05 -0500 NXPL RXRX XWEL http://www.streetinsider.com/Press+Releases/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html <p>DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning’s tape highlights companies positioning for scale in 2026 and beyond.</p> <p><strong>Totaligent Targets APAC Biologics and Medical Tourism</strong></p> <p>Totaligent (OTCID: TGNT) announced the execution of a <strong>binding Letter of Intent (LOI)</strong> with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent’s recently announced Aetherium Medical platform.</p> <p>The agreement establishes a JV http://www.streetinsider.com/Press+Releases/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html Wed, 25 Feb 2026 09:38:05 -0500 NXPL RXRX XWEL http://www.streetinsider.com/Press+Releases/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html <p>DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning’s tape highlights companies positioning for scale in 2026 and beyond.</p> <p><strong>Totaligent Targets APAC Biologics and Medical Tourism</strong></p> <p>Totaligent (OTCID: TGNT) announced the execution of a <strong>binding Letter of Intent (LOI)</strong> with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent’s recently announced Aetherium Medical platform.</p> <p>The agreement establishes a JV http://www.streetinsider.com/Press+Releases/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html Wed, 25 Feb 2026 09:38:05 -0500 NXPL RXRX XWEL http://www.streetinsider.com/Globe+Newswire/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html <p>DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning’s tape highlights companies positioning for scale in 2026 and beyond.</p> <p><strong>Totaligent Targets APAC Biologics and Medical Tourism</strong></p> <p>Totaligent (OTCID: TGNT) announced the execution of a <strong>binding Letter of Intent (LOI)</strong> with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent’s recently announced Aetherium Medical platform.</p> <p>The agreement establishes a JV http://www.streetinsider.com/Globe+Newswire/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html Wed, 25 Feb 2026 09:38:05 -0500 NXPL RXRX XWEL http://www.streetinsider.com/Globe+Newswire/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html <p>DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning’s tape highlights companies positioning for scale in 2026 and beyond.</p> <p><strong>Totaligent Targets APAC Biologics and Medical Tourism</strong></p> <p>Totaligent (OTCID: TGNT) announced the execution of a <strong>binding Letter of Intent (LOI)</strong> with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent’s recently announced Aetherium Medical platform.</p> <p>The agreement establishes a JV http://www.streetinsider.com/Globe+Newswire/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html Wed, 25 Feb 2026 09:38:05 -0500 NXPL RXRX XWEL http://www.streetinsider.com/Globe+Newswire/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html <p>DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning’s tape highlights companies positioning for scale in 2026 and beyond.</p> <p><strong>Totaligent Targets APAC Biologics and Medical Tourism</strong></p> <p>Totaligent (OTCID: TGNT) announced the execution of a <strong>binding Letter of Intent (LOI)</strong> with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent’s recently announced Aetherium Medical platform.</p> <p>The agreement establishes a JV http://www.streetinsider.com/Globe+Newswire/AI+Biotech%2C+APAC+Expansion%2C+and+Balance+Sheet+Rebuilds+Set+the+Morning+Tone/26056689.html Wed, 25 Feb 2026 09:38:05 -0500 NXPL RXRX XWEL http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+24/26056014.html si-local-file:///var/storage/secattach/20260225/26056014.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+24/26056014.html Wed, 25 Feb 2026 08:50:00 -0500 O.08204144 XWEL http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+24/26056014.html si-local-file:///var/storage/secattach/20260225/26056014.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++XWELL%2C+Inc.+++++++++++++++For%3A+Feb+24/26056014.html Wed, 25 Feb 2026 08:50:00 -0500 O.08204144 XWEL http://www.streetinsider.com/Equity+Offerings/XWELL+raises+%2431.3+million+in+private+placement/26051710.html <p>XWELL Inc. (NASDAQ: XWEL) announced it entered into a securities purchase agreement with American Ventures, LLC for a private placement expected to generate gross proceeds of approximately $31.3 million before fees and expenses.</p> <p>The private placement involves the sale of approximately 31,333 shares of Series H Convertible Preferred Stock at $1,000 per share, convertible into 66,666,669 shares of common stock at $0.47 per share. The transaction also includes warrants to purchase up to 66,666,669 shares of common stock, exercisable immediately at $0.345 per share with a three-year expiration period.</p> <p>The transaction was priced at market under Nasdaq rules and is expected to http://www.streetinsider.com/Equity+Offerings/XWELL+raises+%2431.3+million+in+private+placement/26051710.html Tue, 24 Feb 2026 16:15:11 -0500 XWEL http://www.streetinsider.com/Press+Releases/XWELL+Announces+Approximately+%2431.3+Million+Private+Placement++Priced+At+The+Market+Under+Nasdaq+Rules/26051692.html <p align="justify">NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses.</p> <p align="justify">The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible http://www.streetinsider.com/Press+Releases/XWELL+Announces+Approximately+%2431.3+Million+Private+Placement++Priced+At+The+Market+Under+Nasdaq+Rules/26051692.html Tue, 24 Feb 2026 16:15:00 -0500 XWEL XWEL http://www.streetinsider.com/Press+Releases/XWELL+Announces+Approximately+%2431.3+Million+Private+Placement++Priced+At+The+Market+Under+Nasdaq+Rules/26051692.html <p align="justify">NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses.</p> <p align="justify">The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible http://www.streetinsider.com/Press+Releases/XWELL+Announces+Approximately+%2431.3+Million+Private+Placement++Priced+At+The+Market+Under+Nasdaq+Rules/26051692.html Tue, 24 Feb 2026 16:15:00 -0500 XWEL XWEL